Scorpion Therapeutics, Inc. sold the stake/assets to Eli Lilly and Company as part of a acquisition on not available.
Deal value was 2500000000 (source: Extracted) Sector: Healthcare; Location: USA.
On the seller side, not available advised, led by Allie Wein, Daniel Wolf, Daniel Goldschmidt, Arjun Karthikeyan, Izaak Lustgarten, LinLin Teng, Jake Kim, Sara Zablotney, Christine Lehman, Palmer Gunderson, Stephen Jacobson, Katherine Nemeth.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Scorpion Therapeutics on sale of PI2.5 billionα inhibitor program to Eli Lilly | The Sponsor - The Sponsor
